NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio

AI Briefing

• – NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio
• – NEXGEL to license and acquire Celularity's regenerative biomaterial products
• – Deal marks significant milestone for NEXGEL's regenerative medicine business